CD4 and infectious disease: Our current work takes advantage of recent immunologic advances to develop a vaccine, which a) is designed to circumvent tolerance by oral vaccination with a mucosal vaccine; b) will be used in infectious disease states for protection against a deadly pathogen that threatens public health; and c) activates intestinal DCs that co-stimulate CD4+ T cell responses specifically to augment weak immune responses, resulting in robust T cell memory.